APRE — Aprea Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Aprea Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	89	53.1	28.8	21.6	22.8
Prepaid Expenses
Total Current Assets	92.4	56.6	30.2	22.5	23.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.359	0.21	0.002	0.088	0.082
Other Long Term Assets
Total Assets	92.8	56.8	30.2	22.7	24
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.3	7.32	3.2	4.39	3.36
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.4	7.32	3.2	4.39	3.36
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	77.4	49.5	27	18.3	20.6
Total Liabilities & Shareholders' Equity	92.8	56.8	30.2	22.7	24
Total Common Shares Outstanding
Total Preferred Shares Outstanding